Vienna - Delayed Quote EUR
The Cigna Group (CIGN.VI)
294.10
-0.90
(-0.31%)
As of 9:05:31 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 15 | 15 | 19 | 19 |
| Avg. Estimate | 60.38B | 61.8B | 252.22B | 263.42B |
| Low Estimate | 58.29B | 60.18B | 248.98B | 256.52B |
| High Estimate | 62.13B | 63.37B | 254B | 268.22B |
| Year Ago Sales | 57.25B | 60.47B | 247.1B | 252.22B |
| Sales Growth (year/est) | 5.47% | 2.19% | 2.07% | 4.44% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CIGN.VI | -- | -- | -- | -- |
| S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Upgrades & Downgrades
| Maintains | Baird: Outperform to Outperform | 4/15/2025 |
| Maintains | Truist Securities: Buy to Buy | 4/11/2025 |
| Initiated | Guggenheim: Buy | 4/9/2025 |
| Maintains | Mizuho: Outperform to Outperform | 4/9/2025 |
| Maintains | Cantor Fitzgerald: Overweight to Overweight | 3/20/2025 |
| Maintains | Truist Securities: Buy to Buy | 2/4/2025 |